AKBAŞ, S. H. Et Al. 2005. The effect of CYP3A5 and P-glycoprotein (MDR-1) polymorphisms on tacrolimus dose requirement in renal transplant patients. European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005) , (Glasgow, United Kingdom).

AKBAŞ, S. H., Keser, I., Bilgen, T., Tuncer, M., Gultekin, M., & Luleci, G., (2005). The effect of CYP3A5 and P-glycoprotein (MDR-1) polymorphisms on tacrolimus dose requirement in renal transplant patients . European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), Glasgow, United Kingdom

AKBAŞ, SADIKA Et Al. "The effect of CYP3A5 and P-glycoprotein (MDR-1) polymorphisms on tacrolimus dose requirement in renal transplant patients," European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), Glasgow, United Kingdom, 2005

AKBAŞ, SADIKA H. Et Al. "The effect of CYP3A5 and P-glycoprotein (MDR-1) polymorphisms on tacrolimus dose requirement in renal transplant patients." European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005) , Glasgow, United Kingdom, 2005

AKBAŞ, S. H. Et Al. (2005) . "The effect of CYP3A5 and P-glycoprotein (MDR-1) polymorphisms on tacrolimus dose requirement in renal transplant patients." European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005) , Glasgow, United Kingdom.

@conferencepaper{conferencepaper, author={SADIKA HALİDE AKBAŞ Et Al. }, title={The effect of CYP3A5 and P-glycoprotein (MDR-1) polymorphisms on tacrolimus dose requirement in renal transplant patients}, congress name={European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005)}, city={Glasgow}, country={United Kingdom}, year={2005}}